Search Results for:
-
INTERFERON WARRANT EXERCISE RAISES $3M
said Thursday that it has received about $3 million through the exercise of warrants to purchase 432,600 shares of common stockBioWorld Today | Friday, March 6, 1992 -
GENZYME LAUNCHES ANOTHER NEOZYME
Each new unit consists of one share of callable common stock of Neozyme II, one warrant to purchase a share of Genzyme common stock (NASDAQ:GENZ) and one callable warrant to purchase a share of Genzyme common stockBioWorld Today | Wednesday, March 4, 1992 -
SYNTRO FILES 3 MILLION-SHARE OFFERING
Syntro Corp., which is developing genetically engineered vaccines for the animal health market, on Monday said it has filed for a secondary offering of 3 million shares of common stockBioWorld Today | Tuesday, March 3, 1992 -
GENDERM FILES INITIAL PUBLIC OFFERING
GenDerm Corp., which develops and markets products to control pain and treat skin and allergic disorders, has filed for an initial public offering of 2.6 million shares of common stock with a proposed price of $12 to $14 a shareBioWorld Today | Monday, March 2, 1992 -
BLECH COMPANIES AGREE TO $50M MERGER
Under the proposed terms, the Alachua, Fla., company would issue 0.75 shares of a new class of convertible common stock, for a total of 12 million Pharmatec shares, in exchange for each of the 16 million Pharmos shares outstanding...He now owns 60 percent of Pharmatec common stock and 19 percent of Pharmos sharesBioWorld Today | Friday, February 28, 1992 -
LTIZ FILES SECONDARY OFFERING
said Thursday that it has filed for an offering of 2 million shares of common stockBioWorld Today | Friday, February 28, 1992 -
CYTRX NETS $25.7M FROM WARRANTS
Each warrant entitled the holder to buy a share of common stock (NASDAQ:CYTR) for $5BioWorld Today | Thursday, February 27, 1992 -
LIDAK ISSUES PREFERRED AND WARRANTS
Each preferred share, which may be converted into a share of common stock (NASDAQ:LDAKA), can be redeemed by the La Jolla, Calif., company for $1.24BioWorld Today | Thursday, February 27, 1992 -
SOMATIX PATENT SUFFERS SETBACK
Somatix this month raised $34.5 million in a secondary offering of 3 million shares of common stock at $11.50 per shareBioWorld Today | Wednesday, February 26, 1992 -
AMGEN TO REPURCHASE SHARES
said Tuesday that it will repurchase on the open market up to $50 million of common stock (NASDAQ:AMGN) before Jan. 31, 1993BioWorld Today | Wednesday, February 26, 1992 -
ICOS BACK TO THE FUNDING WELL
Icos Corp., which is developing products to treat chronic inflammatory diseases, said Monday that it has filed for a secondary offering of 3 million shares of common stockBioWorld Today | Tuesday, February 25, 1992 -
MEDICIS WARRANT REDEMPTION RAISES $14M
The warrants were exercised at $1.50 to purchase one share of common stock (NASDAQ:MDRXA) and one class B warrantBioWorld Today | Tuesday, February 25, 1992 -
TSI SHARES ELIGIBLE FOR CONVERSION
said Monday that all of the 2 million outstanding shares of its convertible preferred stock have become convertible into TSI common stock (NASDAQ:TSIN) on a share- for-share basis...The remainder became convertible after the close of trading last Friday, after the average daily price of the common stock exceeded $9.25 for 90 consecutive business daysBioWorld Today | Tuesday, February 25, 1992 -
IDEXX PLANS SECONDARY OFFERING
has registered an offering of 1.5 million shares of common stock (NASDAQ:IDXXBioWorld Today | Monday, February 24, 1992 -
BLECH, PHARMATECH CLOSE DEAL
Each unit consists of two shares of common stock and one class A warrant...Each A warrant may be exercised for six years at $1.25 to purchase a share of common stock and one class B warrantBioWorld Today | Monday, February 24, 1992 -
SOMATIX OFFERING RAISES $34.5 MILLION
said on Thursday that it raised $34.5 million in a secondary offering of 3 million shares of common stock at $11.50 per shareBioWorld Today | Friday, February 21, 1992 -
INNOVET TO ACQUIRE COLLABORATOR
The common stock closed at $4.75, down 13 cents, on Wednesday. (c) 1997 American Health ConsultantsBioWorld Today | Thursday, February 20, 1992 -
TAXOL MAKER CLOSES PRIVATE PLACEMENT
said Wednesday that it has raised $6.75 million in a private placement of 900,000 shares of unregistered common stock at $7.50 per share (AMEX:ESNBioWorld Today | Thursday, February 20, 1992 -
NOVEN FILES TO SELL 2.5M SHARES
said Tuesday that it has filed for a secondary offering of 2.5 million shares of common stock...The transaction, valued at about $47 million, was to involve Ivax's acquisition of Noven's shares outstanding for $3.50 per share, payable in shares of Ivax common stockBioWorld Today | Wednesday, February 19, 1992 -
HEMACARE REGISTERS SHARES
has registered 700,000 shares of common stock issuable upon exercise of the company's publicly traded warrants...Each warrant is exercisable to purchase one share of common stock (NASDAQ:HEMA) at $3.50 per share until Oct. 21, 1992BioWorld Today | Wednesday, February 19, 1992
Category
Current Filters
- xcommon stock
Related Keywords
Categories
- x BioWorld Today (4979)
- x BioWorld Insight (498)
- x BioWorld International (106)
- x State of the Industry Report (72)
- x BioWorld Snapshots (50)
- x Executive Compensation Report (36)
- x Bio Perspectives (29)
- x BioWorld Genomics Review (15)
BioWorld | 3525 Piedmont Road
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Part of Thompson Media Group LLC
Free Ezine
Sign up for Perspectives FREE e-mail newsletter.
Customer Service: In the U.S. and Canada: 1-800-477-6307
Outside the U.S.: 1-404-262-5476
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Outside the U.S.: 1-404-262-5476
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.